Citations(0)

Content

How to Cite This Article

Download Download [ PDF ]

Email Send to a friend

Page Views Page Views(816)

Facebook ShareFacebook Share

Twitter ShareTwitter Share

Year : 2015 Month : February Volume : 4 Issue : 18 Page : 3057-3064

COMPARATIVE STUDY BETWEEN EPIDURAL BUPIVACAINE WITH BUPRENORPHINE AND EPIDURAL BUPIVACAINE FOR POST-OPERATIVE ANALGESIA IN ABDOMINAL AND LOWER LIMB SURGERY

K. S. Nagesh1, M. Sathesha2, R. S. Prasad3

1. Assistant Professor, Department of Anaestheisology, Sri Jayadeva Institute of Cardiac Sciences & Research, Bannerghatta Road, Jayanagar, Bangalore.
2. Assistant Professor, Department of Anaesthesiology, Bangalore Medical College & Research Institute, Fort Bangalore.
3. Professor, Department of Anaesthesia, Oxford Medical College and Research Institute, Yeduvanahalli, Bangalore.

CORRESPONDING AUTHOR

Dr. M. Sathesha,
Email : drsathesham@gmail.com

ABSTRACT

CORRESPONDING AUTHOR:
Dr. M. Sathesha,
No. 8, 6th Block,
Koramangala,
Bangalore-560095.
E-mail: drsathesham@gmail.com

ABSTRACT: Epidural administration of various analgesics gained increasing popularity following the discovery of opioid receptors in the spinal cord capable of producing potent analgesia. This effect seems to be greatest when epidural anaesthesia in continued in the post-operative period as epidural analgesia. It is now clear that epidural administration of opioids. Ours was a comparative study between epidural bupivacaine with buprenorphine and epidural bupivacaine for post-operative analgesia in abdominal and lower limb surgery. METHODS: 60 patients undergoing lower abdominal and lower limb surgeries of either sex with ASA grade 1 and 2 aged between 20 and 60 years for divided into two groups. After completion of the surgery and when the effect of local anaesthetic wears of and the patients complains of pain the intended study drugs were given when visual analogue pain score touched 5 cm mark. Group – A: Patients received 8ml of 0.25% bupivacaine + 0.15mg of buprenorphine. Group – B: patients received 0.25% of bupivacaine alone. In the post-operative period the following parameters were studied, 1. Onset of analgesia, 2. Duration of analgesia, 3. Vital parameters such as heart beat, blood pressure, respiratory rate, sedation score and visual analogue score were recorded, 4. Side effects like nausea, vomiting, hypotension, respiratory depression, and pruritus allergic reaction were looked for. RESULTS: It is observed that onset of analgesia in Group A (0.25% bupivacaine + 0.15mg buprenorphine) was 7.35 min. When compared to Group B which 15.5 min, which is statically significant (P<0.05). Duration of analgesia in Group A is 17.23 hrs compared to Group B, which is 5.2 hrs, this is statically significant (P<0.05). Visual analogue scale was reduced in Group A compared to Group B CONCLUSIONS: Addition of buprenorphine to bupivacaine by epidural injection for post-operative analgesia improves the onset, The duration and the quality of analgesia.

KEYWORDS: Bupivacaine, Buprenorphine, Post-Operative analgesia, Epidural.

 

INTRODUCTION: The word pain1,2 the derived from Latin word ‘Ponea’ which is an unpleasant sensory and emotional experience associated with actual or potential tissue damage and described in terms of such damage.

Chemical mechanical or thermal stimuli of sufficient quantity or intensity to threaten or destroy tissue or to disrupt vascular integrity typically lead to autonomic (Changes in heart rate and blood pressure) or hormonal (Adrenal and pituitary secretion) responses as well as to the subjective sensation of pain. A wide range of option exists to combat pain both pharmacologically and non-pharmacologically.

Morphine has been used epidurally3,4 for post-operative analgesia but has been associated with delayed respiratory depression. On the invention of buprenorphine which is more potent than morphine and is agonist – antagonist with lipid solubility about 5 times greater than morphine has been used epidurally for post-operative analgesia.

A few clinical report shows even though epidural bupivacaine produces analgesia does not cause side effects of epidural opioids.

This study was envisaged and designed to evaluate the effectiveness of relief of pain, on onset of pain relief and side effect due to epidural administration of bupivacaine with buprenorphine mixture and bupivacaine alone in patients undergoing abdominal and lower limb surgery.

METHODS: After obtaining approval from the institutional ethics committee and inform consent 60 patients undergoing general surgery gynecological and orthopedic surgeries were selected at random. All the patients were aged between 20 and 60 during the preoperative visit detailed preoperative evaluation was done. Laboratory investigations included routine blood (Hb% TC, DC & ESR) urine, blood urea, creatinine, Sugar, ECG, HIV and HBSAG. The procedure was explained to the patient and consent obtained. In the visual analogue scale patients were shown a scale of 10 cm length. Zero end of the scale was taken as ‘No Pain” and 10cm mark as ‘Maximum Pain’. Intensity of the pain increase gradually from 0 to 10 patients was instructed to point the intensity of pain on the scale.

For the purpose of assessing the pain:

0-   2.5 cm taken as no pain

2.5-5 cm taken as mild pain

5-7.5 cm taken as moderate pain

7.5 – 10 cm taken as severe pain

Intraoperative anaesthesia and analgesia5,6 was achieved with lignocaine 2% with adrenaline 1:2, 00, 000, 16-20 ml though the epidural catheter and anaesthesia was topped up with 5ml of 1% lignocaine hydrochloride every 30 min till the end of the surgery.

After completion of surgery patient observed in the recovery room till the level of analgesia wears off to the spinal segment T12 before shifting to post-operative ward.

When the effect local anaesthetic wears of and the patient complains of pain, first assessment of intensity of pain was done by VAS and later study drugs were given when the VAS score touched 5 cm mark.

Group – A: Patients received 8ml of 0.25% bupivacaine + 0.15mg of buprenorphine.

Group – B: patients received 0.25% of bupivacaine alone.

 

In the post-operative period the following parameters were studied:

  1. Onset of analgesia: it was taken as time duration between injection of drug and onset of pain relief.
  2. Duration of analgesia: This was calculated from the time when the first dose of analgesia were give post operatively and followed up till patient complained of pain. Time at which patients complained of pain more than 5 cm on VAS scale was noted.
  3. Vital parameters such as heart rate, blood pressure respiratory sedation score and visual analogue were recorded.
  4. Side effects like nausea, vomiting, hypotension, respiratory depression, and pruritus allergic reaction were looked for.

 

SEDATION SCORE: Grade 1 to 6:

  1. Deep sleep – does not respond to verbal commands.
  2. Sleepy – responds to verbal commands.
  3. No complaint or body movement-calm.
  4. Complaints with body movement – But calm.
  5. Substantial complaining and body movement – not calm.
  6. A great degree of complaining and body movement accompanied by some excitement.

 

Statistical analysis was done using Chi-square test, student t-test (paired and unpaired t-test), A P value of < 0.05 was considered significant, <0.01 – highly significant, <0.001 – very highly significant, > 0.05 not significant.

 

RESULTS:

  1. 1.      On set of Analgesia: It is observed that onset of analgesia in Group A (0.25% bupivacaine + 0.15mg buprenorphine) was 7.35 min. when compared to Group B (0.25% bupivacaine) which was 15.50 min, which is statistically significant (P<0.05) it shows bupivacaine with buprenorphine has faster onset of pain relief when compared to bupivacaine alone given epidurally.
  2. 2.      Duration of Analgesia: Duration of analgesia in Group A is 17.23 hrs compared to Group B which is 5.2 hrs. This is statistically significant (P<0.05)
  3. 3.      VAS Score- when compared to two groups the VAS score was reduced in Group A when compared to Group B.
  4. 4.      Sedation Score: It was found that there was highly significant increase in sedation score with Group A.

 

There was no significant change in heart rate, blood pressure, respiratory rate between the two groups.

SIDE EFFECTS: Side effects like nausea, vomiting, hypotension, respiratory depression, and pruritis and hypotension was studied. We observed that nausea, vomiting, and retention of urine was more in Group A.

DISCUSSION: In the post-operative period when the effect of anaethetic disappears, the tissue injury persists and pain introducing substances which liberated during the operation greatly reduce the normally high threshold of the nociceptors,7,8 so that innocuous stimulation produces pain, moreover the cut ends of axons further contributed to nociception.

Traditionally epidural bupivacaine was used for post-operative analgesia. Epidural bupivacaine 0.05% causes motor, sensory and sympathetic blockade, 0.25% causes sensory and autonomic blockade and 0.125% causes autonomic blockade only.

Buprenorphine9,10 was 30 times more potent that morphine and has high lipid solubility and which has been used epidurally with lower incidence of respiratory depression.11,12

Onset of analgesia is taken as time interval between the blood administration and the time when patient started getting pain relief mean time of onset of analgesia is Group A was 7.53 min and Group B was 15.50 min.

The onset of analgesia was significant faster in Group A compared to Group B.

Zenz M, Pipenbrocks S,13 did a double blind comparison of epidural buprenorphine and epidural morphine for postoperative pain relief. Both substances produce analgesia with a short latency of 6.8 min. which is close to our observation of 7.53 min.

Duration of analgesia in our study the main duration of analgesia in Group A was 17.23 hrs which significantly higher compared to Group B of mean duration of analgesia of 5.2 hrs. The rapid onset of action and long duration of analgesic effect of buprenorphine can be explained by high liquid solubility of buprenorphine and it’s high affinity to opioid receptors.

ON CARDIO VASCULAR SYSTEM: The objective parameters of analgesia like mean arterial pressure and heart rate were compared and reduction in MAP was statically significant in Group A compared to Group B.

In Group A MAP from base line 98.3 mmHg fell to 90.8 mmHg at 30 min then picked up to 94.92 at 11th hour remained same throughout the study. In Group B MAP from baseline 93.97 mmHg fell to 8.43 mmHg at 10 min then picking up slowly to 93.7 mmHg at 1st hour thereafter remained significantly high throughout the study. The mean HR reduction indicating analgesia was also significant in Group A compared Group B. The mean base line heart rate in Group A was 94.3 min-1 reduced gradually to 80.66 at 1hr and remained low throughout the study. The mean base line heart rate which was in Group B 81.76 min-1 went up to 87.3 at 10 min-1 then significantly remained higher throughout the study.

The study done by Cahill J14 and others showed epidural buprenorphine had no serious haemodynamic derangements.

ON RESPIRATORY RATE: In Group A mean base line respiratory rate from 17.7 min-1 fell to around 15.9 in 30 min gradually reducing to 12.56 by 7th hr, picking up slightly by 11th hr again falling to 12.76 by 15th hr and gradually raise to 14.26 by 21st hr. Zenz M and Coworker13 when comparing epidural buprenorphine and epidural Morphine observed decrease respiratory rate and increase tidal volume however there was no severe respiratory depression.

In Group A there was slight delayed minimal respiratory rate fall this correlates to the above mentioned study.

In Group b baseline respiratory which was 15.2 fell to 14.76 at 20th min remaining stationary throughout the study.

SEDATION: In Group A patients had moderate drowsiness (Grade II). All the patients woke up when pulse and bold pressure were recorded. The sedative effect of buprenorphine was desirable in the immediate post-operative period.

SIDE EFFECTS: In our study the incidence of nausea and vomiting in Group A was 16.5% and the Group B was 3.3%. no. patients reported Pruritus or hypotension or urinary retention.

REFERENCES:

1.    Philip J, Siddall and Michael J, cousins (1998): Neural blockade in clinical Anesthesia and Management of Pain, 3rd edition by M.J. Cousins and P.O Bridenbergh, Lippincott — Raven Publishers Chapter 23.1, P. 675.
2.    Henry J. Mc Quay 1994. Epidural analgesics in text book of pain. 3'd edition, Churchill Livingstone, edited by Pairic D. Wall, Ronald Melzack, chapter 53: 1025-26.
3.    Hart EM, Ahmed N and Buggy DJ. (2003): Impact study of the introduction of low dose epidural (bupivacaine 0.1%/ fentanyl) compared with bupivacaine 0.25% for labour analgesia. Int. J. Obstet Anesth. 2003 Jan; 12(1): 4-8.
4.    Bonicas Management of Pain. Third Edition.
5.    Ronald Melzack - Text book of pain, 4th edition.
6.    Tuman KJ, Mc Carty RJ, March RJ et al: 'Effects of epidural anesthesia and analgesia on coagulation and outcome after major vascular surgery. Anesth. Analg, 73: 686, 1991.
7.    Tuman KJ, Mc Carthy RJ, spices BD: Epidural anaesthesia and analgesia decreases post-operative hyper coagulability in high risk vascular patients'. Anesth. Analgy, 70: S414, 1990.
8.    Goodman and Gilman (1990). 'The Pharmacological basis of therapeutics', 8th edition, Pergamon press: 495, 513-514.
9.    Vickers MD, Morgan M, Spencer PSJ, Read MS (1999). 'Drugs in Anaesthetic and intensive care practice', 8"1 Ed., Butterworth Heinemann: 50-51, 201-202.
10.    Wood and Wood (1990), 'Drugs and Anaesthesia' 2nd Ed, William and Wikkins. Pg. 166-167.
11.    Robert K. Stoelting (1999), 'Pharmacology and Physiology in Anaesthesia practice', 3d Ed, Lippincott Raven P. 105-106.
12.    Vincent J. Collins (1978) 'Physiologic and Pharmacologic basis of Anaesthesia', 29d Ed. William and Wilkins: 573-574.
13.    Zenz M., Pipen brock S., Hubner B., Glocke M: 'A double blind comparison of epidural Buprenorphine and epidural morphine in post-operative pain'. Anaesth - Intensive therapy — Notfallmed, 16(6): 333-9, 1981.
14.    Cahill J., Murphy D., 0. Brien D et at; Epidural Buprenorphine for pain relief after major abdominal surgery. Anaesthesia, 38: 760, 1983.

 

No. of

Patients

Mean onset

of analgesia

(in min)

SD

t

Significance

Group A

30

7.52

2.71

2.38

P<0.05. significant

Group B

30

15.50

1.50

Table 1: Onset of Analgesia

 

 

No. of

Patients

Mean onset

of analgesia

(in min)

SD

t

Significance

Group A

30

17.23

2.8

 

2.80

 

P<0.05. S

Group B

30

5.20

0.66

Table 2: Duration of Analgesia

 

Time Interval

HR

t

Significance

 

Group A

Group B

 

 

 

Mean

SD

Mean

SD

 

 

0

94.3

6.34

81.76

7.44

 

 

10 Min

88.13

6.66

87.13

5.81

0.54

P>0.05 NS

20 Min

88.66

4.99

87.4

7.00

0.642

P>0.05 NS

30 Min

84.86

5.34

86.9

6.88

0.21

P>0.05 NS

1 Hour

80.66

6.15

86.2

6.97

0.002

P>0.05

3 Hour

80.33

6.43

85.0

6.59

0.01

P>0.05 NS

5 Hour

82.00

7.20

85.87

7.29

0.04

P>0.05

7 Hour

81.86

7.20

87.53

7.49

0.004

P>0.05 NS

Table 3: Mean of mean heart rate in between Group A & Group B

 

SD: Standard Deviations, NS: Not Significant

 

Time Interval

MAP

 

t

Significance

 

Group A

Group B

 

 

 

Mean

SD

Mean

SD

 

 

0

98.3

5.45

93.97

9.47

 

 

10 Min

96.5

5.82

83.47

6.97

1.04

P>0.05 NS

20 Min

92.97

6.85

87.7

7.09

0.005

P>0.05 NS

30 Min

90.8

6.78

89.37

7.56

0.44

P>0.05 NS

1 Hour

90.53

8.74

93.7

6.41

0.12

P>0.05 NS

3 Hour

91.77

6.89

97.5

4.99

0.0005

P>0.05 NS

5 Hour

91.93

7.74

97.9

4.82

0.0006

P>0.05 NS

7 Hour

93.33

7.42

99.23

5.33

0.001

P>0.05 NS

Table 4: Mean of MAP in between Group A & Group B at different time intervals

 

                SD: Standard Deviations, NS: Not Significant

 

Time Interval

RR

t

Significance

 

Group A

Group B

 

 

 

Mean

SD

Mean

SD

 

 

0

17.7

1.29

15.2

1.374

 

 

10 Min

16.96

1.35

15.133

1.136

6.46

P<0.05 S

20 Min

16.2

1.09

14.766

1.651

6.11

P<0.05 S

30 Min

15.9

1.15

15.33

1.268

0.08

P<0.05 S

1 Hour

16.3

1.54

15.6

1.28

0.15

P>0.05 NS

3 Hour

14.73

1.98

14.83

1.80

0.84

P>0.05 NS

5 Hour

13.03

2.00

14.87

1.33

0.0001

P>0.05 NS

7 Hour

12.56

1.79

14.67

1.86

3.99

P<0.05 S

Table 5: Mean Respiratory Rate in between

Group A & Group B at different time intervals

 

SD: Standard Deviations, NS: Not Significant, S: Significant

 

Time Interval

VAS

t

Significance

 

Group A

Group B

 

 

 

Mean

SD

Mean

SD

 

 

0

5.13

0.63

5.9

0.88

 

 

10 Min

4.23

0.72

5.55

0.65

4.78

P<0.05 S

20 Min

3.33

0.63

4.10

0.92

0.0006

P>0.05 NS

30 Min

2.7

0.89

2.68

0.855

0.941

P>0.05 NS

1 Hour

1.12

0.715

2.93

0.45

5.17

P<0.05 S

3 Hour

1.3

0.59

4.0

0.91

1.09

P>0.05 NS

5 Hour

1.68

0.61

5.4

0.56

2.49

P>0.05 NS

7 Hour

2.53

0.75

5.76

0.50

3.45

P<0.05 S

Table 6: Comparison of VAS in between Group A & Group B

 

                SD: Standard Deviations, NS: Not Significant, S: Significant

 

Time Interval

SEDATION SCORE

t

Significance

 

Group A

Group B

 

 

 

Mean

SD

Mean

SD

 

 

0

4.16

0.69

4.03

0.490

 

 

10 Min

3

0.371

3.9

0.80

6.84

P<0.05 HS

20 Min

3.03

0.18

2.97

0.614

0.57

P>0.05 NS

30 Min

2.53

0.50

3.03

0.414

9.87

P<0.05 HS

1 Hour

2.9

0.48

2.87

0.571

0.81

P>0.05 NS

3 Hour

3

0

3.2

0.484

0.03

P<0.05 S

5 Hour

3

0

3.57

0.678

2.58

P>0.05 NS

7 Hour

3

0

3.17

6.38

0.02

P<0.05 S

Table 7: Mean Sedation Score

 

SD: Standard Deviations, NS: Not Significant, S: Significant, HS: Highly Significant

 

 

 

 

Videos :

watch?v